MÆDICA - a Journal of Clinical Medicine Logo
  • Home
  • Profile
  • Standards
    • Types of articles
    • Instructions for authors
    • Editing rules (peer-review protocol)
    • Official Journal’s protocols
  • Editorial Council
  • Peer-review TEAM
  • How to
  • Menu

Author archives

  • About
  • Latest Posts

Gabriel STEFAN

Latest posts by Gabriel STEFAN (see all)

  • Metabolic Acidosis of Chronic Kidney Disease and Cardiovascular Disorders - December 21, 2018
  • Renal Transplantation in Romania: Where Do We Stand? - December 21, 2015

Articles signed on MÆDICA, JCM:

Metabolic Acidosis of Chronic Kidney Disease and Cardiovascular Disorders

SELECT ISSUE


MÆDICA - a Journal of Clinical Medicine | Vol. 13, nr. 4, 2018
CNCSIS - CMR - B+ OBBCSSR

Members Area


Metabolic Acidosis of Chronic Kidney Disease and Cardiovascular Disorders

Simona STANCU, Gabriel MIRCESCU, Andreea MOCANU, Cristina CAPUSA and Gabriel STEFAN

ABSTRACT

The burden of chronic diseases, which include both cardiovascular diseases (CVD) and chronic kidney disease (CKD), is constantly growing worldwide. Moreover, bidirectional links between kidney and heart disorders are commonly recognized and the pathogenesis of these interactions is a matter of current interest in medicine. One remarkable aspect, extensively showed by epidemiological studies, is the very high prevalence of CVD in patients with CKD, up to thirty times higher than in the general population. Since the traditional cardiovascular risk factors cannot solely account for this difference, numerous abnormalities due to the decline in glomerular filtration rate were hypothesized to be involved as non-traditional risk factors for CVD. Among them, the metabolic acidosis frequently seen in advanced CKD was studied, but conflicting results were reported. Therefore, we intend to briefly summarize the current knowledge and points of controversy regarding the possible influence of CKD-related chronic metabolic acidosis on cardiovascular diseases.
Keywords: acidosis, bicarbonate, cardiovascular disease, chronic kidney disease, vascular calcifications.

Full text | PDF

Renal Transplantation in Romania: Where Do We Stand?

SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 10, nr. 4, 2015 CNCSIS - CMR - B+ OBBCSSR

Members Area


Renal Transplantation in Romania: Where Do We Stand?

Gabriel STEFAN, Liliana GARNEATA, Dorina TACU, Cristina BUCSA, Ioanel SINESCU and Gabriel MIRCESCU

ABSTRACT

Introduction: According to the Romanian Renal Registry (RRR), only 8% of patients on renal replacement therapy (RRT) in 2012 received a kidney transplant (KTx). As not all transplant centers report to RRR, the outcome of transplanted patients in Romania is not known. Therefore, we aimed to evaluate the outcome in patients grafted in one of the largest transplant center in the country as compared to hemodialysis (HD) and peritoneal dialysis (PD) patients recorded by the RRR.

Method: In an intention-to-treat analysis using Kaplan-Meier and Cox proportional hazard (CPH) models, survival was compared between 8050 incident HD, 1000 PD and 490 KTx patients treated between 2008 and 2011. The patients were stratified by modality at day 90 of therapy.

Results: As compared to HD and PD patients, the KTx recipients were younger, more often of male gender, and had glomerulonephritis as primary renal disease (PRD) more frequently.

KTx patients had a higher mean survival time (57.68 [56.95-58.42] months) than HD (45.55 [45.04-46.06] months) or PD patients (46.33 [45.01-47.65] months). In the multivariate CPH model, higher age (OR=1.03 (1.02-1.03), p<0.01) at RRT initiation, HD (OR=5.60 (3.16-9.94), p<0.01) and PD (OR=5.62 (3.14-10.08), p<0.01) as RRT and diabetic nephropathy (p<0.01) as PRD were associated with a poorer survival.

Conclusion: The present study is the first to provide representative information about the outcome of the KTx patients in Romania. We found that patient survival after KTx is markedly better than either HD or PD. Urgent implementation of a KTx registry is needed in order to improve the national transplantation program.

Keywords: kidney transplantation, hemodialysis, peritoneal dialysis, survival

Full text | PDF



plic-mail[email protected]

 Terms and conditions

© MÆDICA - a Journal of Clinical Medicine - All rights reserved